Tonix Pharmaceuticals Holding Corp (TNXP)

Precedente Chiudi:

$0.1795

Aprire:

$0.18

Volume 24 ore:

670.54K

Capitalizzazione di mercato:

$17.15M

Reddito:

-

Utile/perdita netta:

$-121.02M

Rapporto P/E:

-0.00926

EPS:

-18.6875

Flusso di cassa netto:

$-114.09M

1 W Prestazione:

+11.67%

1M Prestazione:

-5.86%

6M Prestazione:

-69.44%

1 anno Prestazione:

-94.61%

Intervallo 1D:

$0.172

$0.18

Portata 52W:

$0.1202

$3.3125

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Nome

Tonix Pharmaceuticals Holding Corp

Settore

Healthcare (1193)

Industria

Biotechnology (687)

Telefono

862 799 8599

Indirizzo

26 Main Street, Suite 101, Chatham, NY

Dipendente

0

Cinguettio

@TONIXPharma

Prossima data di guadagno

2024-05-22

Ultimi documenti SEC

TNXP's Discussions on Twitter

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-04-18	Iniziato	Noble Capital Markets	Outperform
2019-04-18	Aggiornamento	ROTH Capital	Neutral → Buy
2017-08-18	Aggiornamento	ROTH Capital	Neutral → Buy
2016-09-07	Downgrade	ROTH Capital	Buy → Neutral
2016-02-17	Reiterato	Oppenheimer	Outperform
2015-11-04	Iniziato	Cantor Fitzgerald	Buy
2015-06-12	Iniziato	Oppenheimer	Outperform
2015-02-17	Reiterato	ROTH Capital	Buy
2014-09-29	Reiterato	ROTH Capital	Buy

Mostra tutto

Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

GlobeNewswire Inc.

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024

GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy

GlobeNewswire Inc.

Tonix Pharmaceuticals Holding Corp Azioni (TNXP) Dati Finanziari

Tonix Pharmaceuticals Holding Corp (TNXP) Reddito netto 2024

Tonix Pharmaceuticals Holding Corp (TNXP) Flusso di cassa 2024

Tonix Pharmaceuticals Holding Corp (TNXP) Utile per azione 2024